Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Protein Sciences Corporation, a leading entity in the biotechnology industry, is headquartered in the United States. Founded in 1983, the company has made significant strides in the development of innovative protein-based solutions, particularly in the fields of vaccine production and biopharmaceuticals.
With a focus on advanced protein expression systems, Protein Sciences is renowned for its proprietary technologies, which enhance the efficiency and safety of vaccine manufacturing. Their flagship product, the Flublok® vaccine, stands out for its unique recombinant technology, offering a more effective alternative to traditional flu vaccines.
Recognised for its commitment to quality and innovation, Protein Sciences has established a strong market position, contributing to public health initiatives and advancing the biotechnology landscape. The company continues to play a pivotal role in addressing global health challenges through its cutting-edge research and development efforts.
+58 vs industry average
Protein Sciences Corporation’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Protein Sciences Corporation yet.
Protein Sciences Corporation, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sanofi, and as such, it inherits emissions data and climate commitments from its parent organisation.
While no absolute emissions figures are provided, Protein Sciences Corporation aligns its climate initiatives with those of Sanofi, which has established various reduction targets and commitments. These include participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded from Sanofi at a corporate family level.
Despite the absence of specific emissions data, Protein Sciences Corporation is committed to sustainability and reducing its carbon footprint in line with industry standards. The company is expected to follow the climate strategies and reduction targets set by Sanofi, which are designed to mitigate climate impact and promote environmental responsibility.
No climate goals have been disclosed for Protein Sciences Corporation yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Protein Sciences Corporation yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more